PRS31 SHOULD SALMETEROL/FLUTICASONE PROPIONATE (SAL/FP) BE ADDED TO ROUTINE COPD TREATMENT WITH FENOTEROL/ IPRATROPIUM BROMIDE (FEN/IB)? PHARMACOECONOMIC ASSESSMENT OF COPD TREATMENT BASED ON OBSERVATIONAL RESEARCH (PHACTOR)
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72263-X
https://www.valueinhealthjournal.com/article/S1098-3015(11)72263-X/fulltext
Title :
PRS31 SHOULD SALMETEROL/FLUTICASONE PROPIONATE (SAL/FP) BE ADDED TO ROUTINE COPD TREATMENT WITH FENOTEROL/ IPRATROPIUM BROMIDE (FEN/IB)? PHARMACOECONOMIC ASSESSMENT OF COPD TREATMENT BASED ON OBSERVATIONAL RESEARCH (PHACTOR)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72263-X&doi=10.1016/S1098-3015(11)72263-X
First page :
A324
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
421